COMMUNIQUÉS West-GlobeNewswire

BELLUS Santé annonce la fixation du prix de son placement d’actions ordinaires de 35 millions de dollars
11/12/2018
NE PAS DISTRIBUER AUX AGENCES DE TRANSMISSION AMERICAINES NI DIFFUSER AUX ÉTATS-UNIS LAVAL, Québec, 11 déc. 2018 (GLOBE NEWSWIRE) -- BELLUS Santé inc. (TSX : BLU) (« BELLUS Santé » ou la « société »), une société [...]
Admera Health Genetic Tests are Now In-Network with CareFirst BlueCross BlueShield, Maryland, Washington D.C, and Northern Virginia
11/12/2018
SOUTH PLAINFIELD, N.J., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Admera Health ( www.admerahealth.com ), an advanced molecular diagnostics company, announced today that its genetic testing services are now available as in- [...]
NanoVibronix Announces Selection of Leading International Contract Manufacturer to Support Rapid Scale-up, Lower Price Points and Enhance Profitability
11/12/2018
ELMSFORD, N.Y., Dec. 11, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today [...]
Groundbreaking animal wellness company PetVivo Holdings Inc., an emerging bio-medical company, announces the formation of nonprofit PetVivo Cares
11/12/2018
Nonprofit PetVivo Cares mission is to help extend the life of service animals by providing animal nonprofits with a revolutionary osteoarthritis treatment called Kush ™ MINNEAPOLIS, Dec. 11, 2018 (GLOBE NEWSWIRE) -- [...]
Westleaf Cannabis is Redefining Retail Across Canada -- CFN Media
11/12/2018
Seattle, WA, Dec. 11, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication [...]
Farmako: Cannabis distributor to become gateway to Europe
11/12/2018
Company is first to apply for a licence in the United Kingdom AAA-Team pushes to become gateway to Europe Company first to apply for distribution licences in UK Support of Canadian LP to obtain EU-GMP Focus on research [...]
Eve & Co Announces Product Release
11/12/2018
TORONTO, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (TSX-V: EVE; OTCQB: EEVVF) (“Eve & Co” or the “Company”) is pleased to announce that its initial product line is now available for purchase on the [...]
Avadel Pharmaceuticals Appoints Kevin Kotler to the Company’s Board of Directors
11/12/2018
DUBLIN, Ireland, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on providing innovative medicines for chronic urological, central nervous system, and sleep disorders, [...]
Sapience Therapeutics to Present at Biotech Showcase 2019
11/12/2018
HARRISON, N.Y., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Sapience Therapeutics, Inc., a biotechnology company focused on the discovery and development of peptide therapeutics to address difficult to treat oncology indications [...]
Cellectar Granted Japanese Patent for CLR 131
11/12/2018
Patent covers composition of matter and use in solid and liquid tumor cancer indications FLORHAM PARK, N.J., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB), a clinical-stage [...]
Sarepta Therapeutics Appoints Mary Ann Gray, Ph.D., to its Board of Directors
11/12/2018
- Gray Recognized for Scientific and Financial Acumen as Board Leader - CAMBRIDGE, Mass., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare [...]
Medifirst Solutions to Present at the American Pain Association Conferences Focusing on Medical CBD and the Opioid Epidemic
11/12/2018
Freehold, NJ, Dec. 11, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- MEDIFIRST SOLUTIONS, INC. (OTC: MFST) (the “Company” or “Medifirst”), a provider of innovative laser technology with its FDA 510(k) cleared Infrared [...]
MyoKardia Reports Positive Data from Phase 1b Single-Ascending Dose Clinical Trial of MYK-491 in Dilated Cardiomyopathy and Systolic Heart Failure Patients
11/12/2018
MYK-491 Demonstrated Increase in Contractility Consistent with Data from Preclinical and Healthy Volunteer Studies Multiple-Ascending Dose Phase 2a Clinical Trial in DCM and Systolic Heart Failure Patients Underway [...]
Aptinyx to Present Preclinical Data on NMDA Receptor Modulator NYX-2925 at the American College of Neuropsychopharmacology’s Annual Meeting
11/12/2018
EVANSTON, Ill., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Aptinyx Inc. (NASDAQ: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, [...]
Aravive Biologics Initiates Phase 1b Portion of Phase 1b/2 Clinical Trial of AVB-S6-500 in Platinum-Resistant Recurrent Ovarian Cancer
11/12/2018
HOUSTON, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV), a clinical-stage biopharmaceutical company, today announced that the company has begun treating patients in the Phase 1b portion of a Phase 1b/ [...]
Arch Biopartners Forms New Subsidiary to Pursue a Phase I Trial in Australia for Metablok (LSALT Peptide)
11/12/2018
TORONTO, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (Arch or the Company) (TSX Venture: ARCH and OTCQB: ACHFF) today announced it has formed a 100% owned subsidiary in Australia, named Arch Clinical Pty [...]
Rafael Pharmaceuticals Announces Initiation of Pivotal Phase 3 Trial (AVENGER 500) of CPI-613 (devimistat) in Combination with Modified FOLFIRINOX as First Line Treatment for Patients with Metastatic Pancreatic Cancer
11/12/2018
Interim analysis expected as early as Q2 2020 Newark, NJ, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc. (Rafael), a leader in the growing field of cancer metabolism-based therapeutics, today announced [...]
NexImmune Granted Key US Patent for Core E+E Technology
11/12/2018
GAITHERSBURG, Md., Dec. 11, 2018 (GLOBE NEWSWIRE) -- NexImmune, an emerging leader in the field of antigen-directed immunotherapy, today announced that the United States Patent and Trademark Office has issued a new [...]
ImmuCell Announces USDA Approval of Dual-Force™ First Defense®
11/12/2018
PORTLAND, Maine, Dec. 11, 2018 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and [...]

Pages